PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1705841
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1705841
Global Angiography Equipment Market is estimated to be valued at USD 14.33 Bn in 2025 and is expected to reach USD 21.13 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | USD 14.33 Bn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 5.70% | 2032 Value Projection: | USD 21.13 Bn |
Angiography equipment is commonly used in hospitals and diagnostic centers for minimally invasive surgeries. It helps doctors visualize the insides of blood vessels and organs with high precision. The growing prevalence of cardiovascular diseases and increasing investments in healthcare infrastructure are major factors fueling the demand for angiography equipment. Advancements in imaging technologies like flat panel detectors are enabling manufacturers to develop new generation systems with better image quality and precision. Moreover, rising healthcare expenditure per capita in developing countries creates a conducive environment for market growth over the coming years.
Market Dynamics:
The global angiography equipment market is driven by the rising geriatric population susceptible to conditions like arteriosclerosis and coronary artery disease. Cardiovascular diseases have emerged as a leading cause of mortality worldwide, which is increasing the need for angiography procedures. However, market expansion is negatively impacted by the high installation and maintenance costs of these systems. Stringent regulatory approvals also delay new product launches. On the positive side, manufacturers are continuously innovating to develop low-cost angiography devices suitable for hospitals and clinics in price-sensitive markets. Growing medical tourism in Asia Pacific provides new opportunities for market participants.
On the other hand, market players are focused on adopting various business development strategies, such as product approval from the U.S. Food and Drug Administration and others, which in turn is expected to fuel market growth over the forecast period. For instance, in July 2022, Siemens Healthineers, a global medical device company, announced U.S. Food and Drug Administration (FDA) clearance of the ARTIS icono ceiling, a ceiling-mounted angiography system designed for a wide range of routine and advanced procedures in interventional radiology (IR) and cardiology. The system's high degree of mechanical flexibility also makes it suitable for many surgical procedures.